TABLE 3.

Number of clinically important isolates in 714 urine samples in study B

SpeciesNo. of isolatesNo. of clinically important isolates detected with:
DipStreak device with US3 mediumUS3 medium platesCLED medium
TotalPure≥105 CFU/ml<105 CFU/mlTotalPure≥105 CFU/ml<105 CFU/mlTotalPure≥105 CFU/ml<105 CFU/ml
Candida spp.1515101231510123149122
Citrobacter spp.15151115015111501511150
Escherichia coli 420419361401184203603992141536539916
Enterobacter spp.12128120128120128120
Enterococcus spp.136132701171513570118171367011818
Klebsiella spp.70705966470576377057664
Ochrobactrum anthropi 1111011101110
PMP groupa65655061465496146548614
Pseudomonas spp.43432742143274124327412
Serratia marcescens 3323032303230
Staphylococcus aureus 7767076707670
Staphylococcus spp.8848084808480
Streptococcus agalactiae 15151415015141501514150
Total810805623b76045809619c75554804622d75846
  • a PMP group, Proteus-Morganella-Providencia group.

  • b Five cultures yielded a double bacterial isolation on US3 and CLED medium plates, but only one strain was identified on DipStreak US3 medium.

  • c One cultures yielded a double bacterial isolation on DipStreak US3 and CLED media, but only one strain was identified on US3 medium plates.

  • d Five urine samples with a double bacterial isolation contained two E. coli variants, but only one strain was identified on CLED medium.